Breaking News on Global Pharmaceutical Technology & Manufacturing

Headlines > Ingredients

Loading...
Special Video Report

An exclusive look inside SAFC's HPAPI plant in Verona, Wisconsin

By Claire Videau and Gareth Macdonald , 03-Aug-2010
Last updated the 03-Aug-2010 at 16:07 GMT

Greater recognition of toxicity risks of HPAPIs and continued growth of oncology sector are driving drug industry demand for safe manufacturing capacity says US fine molecules firm SAFC Pharma.

Earlier this year in-Pharmatechnologist visited SAFC’s new high potency active pharmaceutical ingredient (HPAPI) manufacturing facility in Verona, Wisconsin to take a look at its capabilities and speak about the market with operations director David Bormett.

Bormett explained that the new plant had been developed using the latest containment technologies to ensure that employees do not come into contact with the potentially toxic compounds being produced there for assessment in clinical trials or for commercial supply.

He added that: "There has been a general trend in the industry to recognise the toxicity of APIs" going on to say that compounds that had been produced using an open handling approach are now being produced using containment technology to eliminate operator exposure.

And in terms of the wider market, Bormett predicted that the specialist containment and production capabilities required for high potency drug manufacturing are an important growth area for SAFC in terms of business development in the global market.

We feel there is a trend… moving toward US manufacturing and being to do GMP manufacturing at a larger scale [at the Verona plant] will differentiate us from the competition.”

He also predicted that, for the foreseeable future, cancer drugs would continue to be the key demand driver, adding that since the Verona facility was completed earlier this year SAFC has received interest from drugmakers in Europe, the US and Japan who are interested in using its manufacturing capacity.

Related products

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Capsugel: Micro-Dosing Tech Can Cut Drug Development by 6 Months

Missy Lowery

Marketing Manager for the Americas, Capsugel

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Thermo Fisher: Single-Use Tech's Evolution and Increased Industry Use

Cory Stevenson & Brandon Pence

Thermo Fisher Scientific

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

ATMI: Single-Use Could Replace Multi-Use, as Potency Increases

Eric Isberg

Global Product Manager, ATMI

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Tech and Regulatory Issues? Biotech/Manufacturing Firms Discuss

Purification bottlenecks, integrating single-use technologies and low cost companies are just some of the...

Happy holidays from William Reed Business Media!

Happy holidays from William Reed Business Media!

The working year is almost done, time to pause from ‘the business’ and embrace...

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Catalent launches softgel products at CPhI: one vegetarian, one anti-abuse

Will Downie

Senior VP Global Vusiness Development & Marketing, Catalent

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

AlpVision's iPhone Tech Offers Authentication in War on Counterfeits

Quincy Mattingly

Regional Manager, AlpVision

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

Customers to Save up to 65% as ASI and Chromatan Pen Single-Use Deal

ASI has teamed up with Chromatan in order to deliver single-use and column-free capture...

Updated IPEC Guide Steers Excipient Manufacturers Away From Unnecessary Tests

John Giannone - incoming IPEC-Americas chairman

Irwin Silverstein, COO and VP of the International Pharmaceutical Excipients...

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

ATMI: Single Use Bioreactors on the Up, but US Tails Europe

Special Report from ATMI's Belgian Facility

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

BASF nutrition president on high-end omega-3, Equateq and the phood “white space”

Walter Dissinger

President , BASF nutrition and health

Optimism is returning to the pharma fine chemicals sector, says analyst

Optimism is returning to the pharma fine chemicals sector, says analyst

Jan Ramakers

Industry consultant, Jan Ramakers Fine Chemical Consulting Group

Capsugel expands liquid fill capsule capabilities

Keith Hutchison,

Senior VP of research and development (R&D) , Capsugel

New filtration tech boosts biomanufacturing yields, says Sartorius

New filtration tech boosts biomanufacturing yields, says Sartorius

Jens Meyer

Product manager for filtration technologies, Sartorius Stedim

Submit good REMS proposals for FDA brownie points, says RAPS author

Submit good REMS proposals for FDA brownie points, says RAPS author

Ed Tabor

VP of strategic drug development , Quintiles

Key Industry Events

 

Access all events listing

Our events, Events from partners...